Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
In the past twenty years, 14 new antiepileptic drugs have been approved for use in the United States and/or Europe. These drugs are eslicarbazepine acetate, felbamate, gabapentin, lacosamide, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, rufinamide, stiripentol, tiagabine, topiramate, vigab...
Saved in:
Main Author: | Matthew D. Krasowski (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2010-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comments on the Eslicarbazepine Acetate Section of the Article 'Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications'
by: Patricio Soares-, et al.
Published: (2010) -
Diabetic nephropathy: newer therapeutic perspectives
by: Krishna C. Keri, et al.
Published: (2018) -
Effectiveness, tolerability and practical application of the newer generation anti-obesity medications
by: Jeffrey S MacDaniels, et al.
Published: (2016) -
Therapeutic drug monitoring in epilepsy clinic: a multi-disciplinary approach
by: Sunee Lertsinudom, et al.
Published: (2014) -
Experimental Therapeutic Strategies in Epilepsies Using Anti-Seizure Medications
by: Rahim F, et al.
Published: (2021)